MOTS-c
$64.99
10 MG

In stock
Buy the GLOW peptide blend at Velora Research. GLOW is a research-grade three-peptide stack combining 50mg of the copper peptide GHK-Cu with 10mg of TB-500 and 10mg of BPC-157 in a single 70mg lyophilized vial. Supplied for in vitro and preclinical investigation of tissue-remodeling, copper-transport, and matrix-research pathways. Each batch is independently HPLC and mass-spec verified at 99% or higher purity, with a downloadable Certificate of Analysis tied to the lot number. Strictly for laboratory research use, not for human, veterinary, or cosmetic use.
Specifications
GLOW peptides are a proprietary three-component research stack from Velora Research. Each 70mg lyophilized vial contains the copper-bound tripeptide GHK-Cu (50mg), the actin-binding peptide TB-500 (10mg), and the pentadecapeptide BPC-157 (10mg). The three peptides are supplied together as a single lyophilized stack so researchers can run protocols that depend on the fixed three-component ratio without separately reconstituting three vials.
Every batch of GLOW is independently verified by a third-party analytical laboratory using high-performance liquid chromatography (HPLC) and mass spectrometry. Each component peptide is tested before blending, and the combined Certificate of Analysis is published on our COAs page and linked from this product page by batch number.
GLOW peptide is the Velora Research naming convention for the GHK-Cu plus Wolverine Blend stack. The name refers to the three research peptides combined in the 70mg vial. Each component has independent published research literature, and the combination is supplied for protocols that investigate the three pathways together.
The three components of the GLOW peptide stack and their published research areas (in research-frame voice only, no therapeutic claims):
GHK-Cu is the copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine. The compound has been studied in cell-culture and preclinical models across copper-transport chemistry, antioxidant and ROS-pathway research, fibroblast-derived collagen Type I synthesis assays, matrix-metalloproteinase expression research, and gene-expression profiling on cell-repair and oxidative-stress-response gene clusters. GHK-Cu is the largest component of the GLOW stack by mass.
TB-500 is a synthetic peptide derived from the actin-binding region of thymosin beta-4 (Tβ4). It has been characterized in preclinical literature as an actin-modulating peptide with documented research activity in cell-migration assays, angiogenesis models, and cell-culture studies of fibroblast behavior.
BPC-157 (Body Protective Compound 157) is a synthetic 15-amino-acid peptide derived from a partial sequence of a body-protection compound found in human gastric juice. Published preclinical research has characterized BPC-157 across growth-factor pathway research, nitric-oxide-pathway research, and angiogenesis-research models. BPC-157 and TB-500 are also supplied together in Velora’s stand-alone Wolverine Blend product.
All mechanisms above are drawn from peer-reviewed preclinical and in-vitro research literature. Velora Research supplies the GLOW peptide blend solely for further laboratory investigation of these pathways. Nothing about the blend or its components is claimed to produce any specific outcome in humans, animals, or cosmetic applications.
The combination of GHK-Cu plus the Wolverine Blend (BPC-157 + TB-500) in a single fixed-ratio vial is selected in research protocols that target the matrix and tissue-research pathway space in parallel. Each component engages distinct molecular targets:
Researchers running studies that benefit from the three molecular pathways in parallel often select the GLOW stack rather than reconstituting three separate vials, both for protocol consistency and for cost efficiency at the per-mg level.
| Attribute | Specification |
| Research name | GLOW peptide blend |
| Alternate names | GLOW peptide stack, GLOW blend |
| Composition | 50mg GHK-Cu + 10mg TB-500 + 10mg BPC-157 (70mg combined) |
| Form | Lyophilized blue-tinted powder (color from GHK-Cu copper coordination) |
| Per-component purity | 99% or higher (HPLC verified independently before blending) |
| Combined COA | Single batch COA covering all three component peptides |
| Storage (lyophilized) | -20°C, sealed, dry, dark (light-sensitive due to GHK-Cu component) |
| Storage (reconstituted) | 2 to 8°C protected from light, single-use aliquots recommended |
| Verification | Independent third-party HPLC and mass spectrometry per component |
| COA access | Batch-specific COA at verify.janoshik.com (linked from this page) |
Velora Research lists the GLOW peptide stack at a single transparent tier:
| Vial size | Price (USD) | Best for |
| 70mg combined | $80.00 (sale price; regular $100.00) | Pilot studies, multi-pathway tissue-research protocols, comparative studies that depend on the fixed three-peptide ratio without separate reconstitution of three vials |
Free US shipping applies on orders over $200. The 70mg GLOW vial nearly clears the free-shipping threshold on its own; adding a vial of bacteriostatic water or any other compound brings the order over the threshold automatically. International orders are accepted in accordance with applicable research regulations.
Researchers evaluating the GLOW stack often weigh it against ordering the components separately from Velora’s catalog. Approximate cost comparison:
| Purchase path | Approximate cost | Considerations |
| GLOW peptide blend (70mg) | $80.00 (sale) | 50mg GHK-Cu + 10mg TB-500 + 10mg BPC-157 in one vial. Single reconstitution. Fixed ratio. One COA covers all three components. |
| Components ordered separately | GHK-Cu 100mg vial ($60) + Wolverine Blend 5mg/5mg vial ($60) = ~$120 for similar combined mass | Two vials, two reconstitutions, two COAs to manage. Higher per-mg cost but allows custom ratios. |
Velora’s GLOW peptide blend ships as a lyophilized powder with a faint blue tint characteristic of the GHK-Cu component’s copper coordination. For in vitro studies, researchers typically reconstitute with bacteriostatic water (0.9% benzyl alcohol) at a concentration matched to the assay protocol. A common pilot ratio for the 70mg combined vial is 5 mL of bacteriostatic water, yielding a 14 mg/mL stock solution of the combined blend (10 mg/mL of GHK-Cu plus 2 mg/mL each of TB-500 and BPC-157). Adjust per study design.
Velora Research supplies bacteriostatic water as a separate product. Please refer to the peer-reviewed literature and to component-specific stability data for protocol-specific reconstitution and handling parameters.
GLOW peptide is Velora Research’s three-component research stack consisting of 50mg GHK-Cu, 10mg TB-500, and 10mg BPC-157 in a single 70mg lyophilized vial. Each component has independent published research literature, and the combination is supplied for protocols that investigate the three molecular pathways together. Velora supplies GLOW as a research compound for in vitro and preclinical investigation only.
The GLOW peptide stack contains 50mg of GHK-Cu (the copper-bound tripeptide glycyl-L-histidyl-L-lysine), 10mg of TB-500 (a synthetic fragment of thymosin beta-4), and 10mg of BPC-157 (Body Protective Compound 157). Total mass per vial is 70mg combined. The composition is published in the specifications block above and on the active Certificate of Analysis.
Velora Research supplies the GLOW peptide blend with per-component HPLC and mass-spec verification, a downloadable Certificate of Analysis tied to the batch number, and US-based 2-day shipping (free over $200). Pricing reflects research-grade per-component verification rather than commodity bulk-blend supply.
Each component peptide (GHK-Cu, TB-500, BPC-157) is independently tested by a third-party analytical laboratory using HPLC for purity and mass spectrometry for identity. The combined Certificate of Analysis covers all three components in the blend and is published on our /coas/ page and linked from this product page by batch number.
Store the lyophilized vial sealed at -20°C in a dry, dark environment. GHK-Cu (the largest component by mass) is light-sensitive, so keep the vial protected from ambient light. Once reconstituted with bacteriostatic water, refrigerate at 2 to 8°C protected from light and use within the stability window established by the research protocol. Avoid repeat freeze-thaw cycles.
Buy the GLOW peptide stack if your protocol calls for the specific 50:10:10 ratio of GHK-Cu, TB-500, and BPC-157, or if you want a single-vial reconstitution covering all three pathways. Order the components separately if your protocol requires only one or two of the peptides, or if you need a custom (non-fixed) ratio. At sale pricing, the GLOW stack is roughly 30 percent more cost-efficient than buying GHK-Cu and Wolverine Blend separately.
Velora Research lists the GLOW peptide blend at $80.00 USD per 70mg vial (sale price; regular $100.00). Free US shipping applies on orders over $200. Pricing reflects per-component HPLC and mass-spec verification of all three peptides.
No. Velora Research supplies the GLOW peptide blend strictly for laboratory research conducted by qualified institutions and research professionals. The product is not packaged, formulated, or quality-controlled for cosmetic, topical-consumer, skincare, or therapeutic use. Although individual GLOW components (especially GHK-Cu) appear in FDA-approved cosmetic formulations under separate manufacturer pipelines, Velora’s GLOW product is a research compound only and is not interchangeable with any consumer skincare formulation.
Velora Research accepts international orders for laboratory research use only. Buyers are responsible for ensuring compliance with all applicable local, state, and national regulations in their jurisdiction prior to purchasing.